Cargando…

ADGRL3 (LPHN3) variants are associated with a refined phenotype of ADHD in the MTA study

BACKGROUND: ADHD is the most common neuropsychiatric condition affecting individuals of all ages. Long‐term outcomes of affected individuals and association with severe comorbidities as SUD or conduct disorders are the main concern. Genetic associations have been extensively described. Multiple stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Acosta, Maria T., Swanson, James, Stehli, Annamarie, Molina, Brooke S. G., Martinez, Ariel F., Arcos‐Burgos, Mauricio, Muenke, Maximilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023939/
https://www.ncbi.nlm.nih.gov/pubmed/27652281
http://dx.doi.org/10.1002/mgg3.230
_version_ 1782453715241795584
author Acosta, Maria T.
Swanson, James
Stehli, Annamarie
Molina, Brooke S. G.
Martinez, Ariel F.
Arcos‐Burgos, Mauricio
Muenke, Maximilian
author_facet Acosta, Maria T.
Swanson, James
Stehli, Annamarie
Molina, Brooke S. G.
Martinez, Ariel F.
Arcos‐Burgos, Mauricio
Muenke, Maximilian
author_sort Acosta, Maria T.
collection PubMed
description BACKGROUND: ADHD is the most common neuropsychiatric condition affecting individuals of all ages. Long‐term outcomes of affected individuals and association with severe comorbidities as SUD or conduct disorders are the main concern. Genetic associations have been extensively described. Multiple studies show that intronic variants harbored in the ADGRL3 (LPHN3) gene are associated with ADHD, especially associated with poor outcomes. METHODS: In this study, we evaluated this association in the Multimodal Treatment Study of children with ADHD (MTA), initiated as a 14‐month randomized clinical trial of 579 children diagnosed with DSM‐IV ADHD‐Combined Type (ADHD‐C), that transitioned to a 16‐year prospective observational follow‐up, and 289 classmates added at the 2‐year assessment to serve as a local normative comparison group (LNCG). Diagnostic evaluations at entry were based on the Diagnostic Interview Schedule for Children‐Parent (DISC‐P), which was repeated at several points over the years. For an add‐on genetic study, blood samples were collected from 232 in the MTA group and 139 in the LNCG. RESULTS: For the 205 MTA participants, 14.6% retained the DISC‐P diagnosis of ADHD‐C in adolescence. For 127 LNCG participants, 88.2% remained undiagnosed by the DISC‐P. We genotyped 15 polymorphic SNP markers harbored in the ADGRL3 gene, and compared allele frequencies for the 30 cases with continued diagnosis of ADHD‐C in adolescence to the other participants. Replication of the association of rs2345039 ADGRL3 variant was observed (P value = 0.004, FDR corrected = 0.03; Odds ratio = 2.25, upper CI 1.28–3.97). CONCLUSION: The detection of susceptibility conferred by ADGRL3 variants in the extreme phenotype of continued diagnosis of ADHD‐C from childhood to adolescence provides additional support that the association of ADGRL3 and ADHD is not spurious. Exploring genetic effects in longitudinal cohorts, in which refined, age‐dependent phenotypes are documented, is crucial to understand the natural history of ADHD.
format Online
Article
Text
id pubmed-5023939
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-50239392016-09-20 ADGRL3 (LPHN3) variants are associated with a refined phenotype of ADHD in the MTA study Acosta, Maria T. Swanson, James Stehli, Annamarie Molina, Brooke S. G. Martinez, Ariel F. Arcos‐Burgos, Mauricio Muenke, Maximilian Mol Genet Genomic Med Original Articles BACKGROUND: ADHD is the most common neuropsychiatric condition affecting individuals of all ages. Long‐term outcomes of affected individuals and association with severe comorbidities as SUD or conduct disorders are the main concern. Genetic associations have been extensively described. Multiple studies show that intronic variants harbored in the ADGRL3 (LPHN3) gene are associated with ADHD, especially associated with poor outcomes. METHODS: In this study, we evaluated this association in the Multimodal Treatment Study of children with ADHD (MTA), initiated as a 14‐month randomized clinical trial of 579 children diagnosed with DSM‐IV ADHD‐Combined Type (ADHD‐C), that transitioned to a 16‐year prospective observational follow‐up, and 289 classmates added at the 2‐year assessment to serve as a local normative comparison group (LNCG). Diagnostic evaluations at entry were based on the Diagnostic Interview Schedule for Children‐Parent (DISC‐P), which was repeated at several points over the years. For an add‐on genetic study, blood samples were collected from 232 in the MTA group and 139 in the LNCG. RESULTS: For the 205 MTA participants, 14.6% retained the DISC‐P diagnosis of ADHD‐C in adolescence. For 127 LNCG participants, 88.2% remained undiagnosed by the DISC‐P. We genotyped 15 polymorphic SNP markers harbored in the ADGRL3 gene, and compared allele frequencies for the 30 cases with continued diagnosis of ADHD‐C in adolescence to the other participants. Replication of the association of rs2345039 ADGRL3 variant was observed (P value = 0.004, FDR corrected = 0.03; Odds ratio = 2.25, upper CI 1.28–3.97). CONCLUSION: The detection of susceptibility conferred by ADGRL3 variants in the extreme phenotype of continued diagnosis of ADHD‐C from childhood to adolescence provides additional support that the association of ADGRL3 and ADHD is not spurious. Exploring genetic effects in longitudinal cohorts, in which refined, age‐dependent phenotypes are documented, is crucial to understand the natural history of ADHD. John Wiley and Sons Inc. 2016-07-18 /pmc/articles/PMC5023939/ /pubmed/27652281 http://dx.doi.org/10.1002/mgg3.230 Text en © 2016 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Acosta, Maria T.
Swanson, James
Stehli, Annamarie
Molina, Brooke S. G.
Martinez, Ariel F.
Arcos‐Burgos, Mauricio
Muenke, Maximilian
ADGRL3 (LPHN3) variants are associated with a refined phenotype of ADHD in the MTA study
title ADGRL3 (LPHN3) variants are associated with a refined phenotype of ADHD in the MTA study
title_full ADGRL3 (LPHN3) variants are associated with a refined phenotype of ADHD in the MTA study
title_fullStr ADGRL3 (LPHN3) variants are associated with a refined phenotype of ADHD in the MTA study
title_full_unstemmed ADGRL3 (LPHN3) variants are associated with a refined phenotype of ADHD in the MTA study
title_short ADGRL3 (LPHN3) variants are associated with a refined phenotype of ADHD in the MTA study
title_sort adgrl3 (lphn3) variants are associated with a refined phenotype of adhd in the mta study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023939/
https://www.ncbi.nlm.nih.gov/pubmed/27652281
http://dx.doi.org/10.1002/mgg3.230
work_keys_str_mv AT acostamariat adgrl3lphn3variantsareassociatedwitharefinedphenotypeofadhdinthemtastudy
AT swansonjames adgrl3lphn3variantsareassociatedwitharefinedphenotypeofadhdinthemtastudy
AT stehliannamarie adgrl3lphn3variantsareassociatedwitharefinedphenotypeofadhdinthemtastudy
AT molinabrookesg adgrl3lphn3variantsareassociatedwitharefinedphenotypeofadhdinthemtastudy
AT adgrl3lphn3variantsareassociatedwitharefinedphenotypeofadhdinthemtastudy
AT martinezarielf adgrl3lphn3variantsareassociatedwitharefinedphenotypeofadhdinthemtastudy
AT arcosburgosmauricio adgrl3lphn3variantsareassociatedwitharefinedphenotypeofadhdinthemtastudy
AT muenkemaximilian adgrl3lphn3variantsareassociatedwitharefinedphenotypeofadhdinthemtastudy